These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20689980)

  • 1. The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor.
    Garcia DG; Amorim LM; de Castro Faria MV; Freire AS; Santelli RE; Da Fonseca CO; Quirico-Santos T; Burth P
    Mol Cell Biochem; 2010 Dec; 345(1-2):29-34. PubMed ID: 20689980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polygodial and its direct derivatives on the mammalian Na
    Garcia DG; Gonçalves-de-Albuquerque CF; da Silva CI; Kiss R; Dasari R; Chandra S; Kornienko A; Burth P
    Eur J Pharmacol; 2018 Jul; 831():1-8. PubMed ID: 29715454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol.
    Garcia DG; de Castro-Faria-Neto HC; da Silva CI; de Souza e Souza KF; Gonçalves-de-Albuquerque CF; Silva AR; de Amorim LM; Freire AS; Santelli RE; Diniz LP; Gomes FC; Faria MV; Burth P
    Mol Cancer; 2015 May; 14():105. PubMed ID: 25976744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K(+)-ATPase and Ras oncogene activity in cancer cells.
    Lefranc F; Xu Z; Burth P; Mathieu V; Revelant G; de Castro Faria MV; Noyon C; Garcia DG; Dufour D; Bruyère C; Gonçalves-de-Albuquerque CF; Van Antwerpen P; Rogister B; Hesse S; Kirsch G; Kiss R
    Eur J Med Chem; 2013 May; 63():213-23. PubMed ID: 23474907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of ATP binding to Na+,K+-ATPase from its stimulation of ouabain binding: studies of the inhibition of Na+,K+-ATPase by a monoclonal antibody.
    Ball WJ
    Biochemistry; 1986 Nov; 25(22):7155-62. PubMed ID: 3026448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of inhibition of brain Na+,K+-ATPase by agelasidines and agelasines from a sea sponge.
    Kobayashi M; Nakamura H; Wu HM; Kobayashi J; Ohizumi Y
    Arch Biochem Biophys; 1987 Nov; 259(1):179-84. PubMed ID: 2825594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR; Saunders JP
    J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thermolability of alpha+-isoform of the catalytic subunit of brain Na+,K+-ATPase].
    Kaplia AA; Kravtsov AV
    Ukr Biokhim Zh (1978); 1990; 62(4):39-44. PubMed ID: 2173186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
    Pôças ES; Costa PR; da Silva AJ; Noël F
    Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inactivation of alpha (+) molecular form of (Na+ + K+)-ATPase by pyrithiamin.
    Matsuda T; Iwata H; Cooper JR
    J Biol Chem; 1984 Mar; 259(6):3858-63. PubMed ID: 6323444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
    Stepp LR; Novakoski MA
    Arch Biochem Biophys; 1997 Jan; 337(1):43-53. PubMed ID: 8990266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of (Na/K)-ATPase by electrophilic substances: functional implications.
    Breier A; Ziegelhöffer A; Stankovicová T; Docolomanský P; Gemeiner P; Vrbanová A
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):187-92. PubMed ID: 7494549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of subunits of cardiac, brain, and kidney Na+-K+-ATPase.
    McDonough A; Schmitt C
    Am J Physiol; 1985 Mar; 248(3 Pt 1):C247-51. PubMed ID: 2983564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane (Na+ + K+)-ATPase of canine brain, heart and kidney. Tissue-dependent differences in kinetic properties and the influence of purification procedures.
    Choi YR; Akera T
    Biochim Biophys Acta; 1978 Apr; 508(2):313-27. PubMed ID: 147705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Na+,K+-ATPase isoenzymes: sensitivity to prednisolone bisguanylhydrazone.
    Ng YC; Leung WY; Akera T
    Eur J Pharmacol; 1988 Oct; 155(1-2):93-9. PubMed ID: 2854075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palytoxin isolated from marine coelenterates. The inhibitory action on (Na,K)-ATPase.
    Ishida Y; Takagi K; Takahashi M; Satake N; Shibata S
    J Biol Chem; 1983 Jul; 258(13):7900-2. PubMed ID: 6134726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
    Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum-induced alterations in [3H]ouabain binding and ATP hydrolysis catalyzed by the rat brain synaptosomal (Na(+)+K+)-ATPase.
    Caspers ML; Dow MJ; Fu MJ; Jacques PS; Kwaiser TM
    Mol Chem Neuropathol; 1994 May; 22(1):43-55. PubMed ID: 7916767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.